Pfizer’s new RSV vaccine may trigger Guillain-Barre syndrome
Pfizer‘s new RSV vaccine for older adults may trigger the potentially deadly Guillain-Barre syndrome, the Food and Drug Administration (FDA) has warned. In clinical trials, two participants in their 60s developed the condition that can also cause crippling pain, muscle weakness and paralysis. One …
Read More